If you have any suggestions for additional content for the COVID-19 Hub, or have any queries regarding the current content, please contact the ESPE Office in order for your suggestion to be reviewed by the ESPE Clinical Practice Committee.

This page is intended to provide developing information and resources for patients and physicians regarding the the effects of COVID on those suffering from paediatric endocrine conditions. Members of the ESPE Clinical Practice Committee and ESPE Working Groups have developed patient and physician information leaflets and have compiled links to relevant resources from other organisations.

Contributing to developing knowledge on COVID-19


The electronic reporting system e-REC (e-Reporting Of Rare Conditions) is part of the European Registries for Rare Endocrine Conditions (EuRRECa) project, funded by EU CHAFEA and supported by  ENDO-ERN, ESE and ESPE. From April 2020, in close collaboration with the ESE Rare Disease Committee, the system has been extended to include the reporting of COVID-19 infection in patients with an existing endocrine or metabolic bone condition. This is open to all centres that look after people with such conditions.  Learn more and contribute to the e-REC database.